PELL Bio-Med Technology Co (TPE:6949) Other Current Payables: NT$170.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$1,025.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co Other Current Payables?

PELL Bio-Med Technology Co TPE:6949 +9.63% 13 Other Current Payables is NT$170.26 Mil as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

PELL Bio-Med Technology Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$170.26 Mil.

PELL Bio-Med Technology Co's quarterly Other Current Payables increased from Jun. 2025 (NT$125.19 Mil) to Sep. 2025 (NT$129.08 Mil) and increased from Sep. 2025 (NT$129.08 Mil) to Dec. 2025 (NT$170.26 Mil).

PELL Bio-Med Technology Co's annual Other Current Payables increased from Dec. 2023 (NT$56.66 Mil) to Dec. 2024 (NT$88.06 Mil) and increased from Dec. 2024 (NT$88.06 Mil) to Dec. 2025 (NT$170.26 Mil).

PELL Bio-Med Technology Co Other Current Payables Related Terms

PELL Bio-Med Technology Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co Other Current Payables Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
23.75 20.76 56.66 88.06 170.26

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.06 92.29 125.19 129.08 170.26
TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$170.26 Mil mean?
PELL Bio-Med Technology Co (TPE:6949) has a Other Current Payables of NT$170.26 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on PELL Bio-Med Technology Co and its competitors.
Is PELL Bio-Med Technology Co's Other Current Payables too high?
PELL Bio-Med Technology Co's current Other Current Payables is NT$170.26 Mil. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Other Current Payables compare to VRTX and REGN?
PELL Bio-Med Technology Co's Other Current Payables of NT$170.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current Other Current Payables is NT$170.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Other Current Payables of NT$170.26 Mil. The current Other Current Payables is NT$170.26 Mil. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Other Current Payables is NT$170.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,025.00
Price